GENMAB A/S -SP ADR (GMAB) Stock Income Statement
NASDAQ:GMAB - Nasdaq - US3723032062 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.92B | 3.25B | 2.48B | 2.19B | 8.42B | |||
| Cost Of Goods | 323.98M | 148.53M | 34.08M | 0.00 | 0.00 | |||
| Gross Profit | 7.60B | 3.10B | 2.45B | 2.19B | 8.42B | |||
| Operating Expenses | 4.95B | 2.03B | 1.65B | 1.24B | 5.46B | |||
| Research and Development | 3.61B | 1.45B | 1.14B | 822.43M | 4.18B | |||
| Selling, General, and Administrative Expenses | 1.34B | 566.08M | 490.38M | 397.79M | 1.27B | |||
| Operating Income | 2.65B | 1.07B | 802.37M | 950.75M | 2.95B | |||
| Interest Income/Expense | 702.69M | 371.10M | 47.65M | 102.24M | 965.00M | |||
| Non Recurring Items | N/A | -56.70M | 0.00 | -5.73M | N/A | |||
| Income Before Taxes | 3.17B | 1.38B | 850.02M | 1.05B | 3.92B | |||
| Income Tax | 799.67M | 199.05M | 193.77M | 225.13M | 961.00M | |||
| Net Income | 2.37B | 1.18B | 656.25M | 822.12M | 2.96B | |||
| EBITDA | 2.73B | 1.13B | 846.85M | 1.01B | 3.20B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.81 | 1.90 | 1.03 | 1.29 | 4.64 | |||
| Non GAAP EPS | 12.72 | 12.58 | 6.84 | 8.67 | 4.72 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.91% | 95.42% | 98.63% | 100.00% | 100.00% | |||
| Profit Margin | 29.96% | 36.44% | 26.42% | 37.59% | 35.13% | |||
| Operating Profit Margin | 33.49% | 32.89% | 32.30% | 43.47% | 35.08% | |||
All data in DKK